Company page

Lantern Pharma Inc.

Lantern Pharma Inc. is a public company traded under the ticker LTRN in the American market. The company has a market capitalization of approximately $35 million. Lantern Pharma focuses on developing targeted cancer therapies using its proprietary technology to improve treatment outcomes for patients.